Advancing the frontiers of clinical drug development

CHDR is an independent institute specialising in innovative early-stage clinical drug research.

Our Story

Our Unit


The IB-Derisk analyser: A practical tool for integrating preclinical findings

10 Sep 2018

Gene therapy studies @ CHDR, how to get started?

09 Sep 2017

Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunt...

28 Aug 2018

Combining innovative methods with state-of-the-art facilities maximises our clients' chance of success

The next generation of multifunction, standardised CNS test batteries

Pre-screened patients on standby for early-stage clinical trials

A robust tool for experimentally inducing panic attacks in order to test new anxiolytics